Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-masked, Placebo-controlled Evaluation of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation

NCT03248037 is registered in ClinicalTrials.gov with Cornea Research Foundation of America as lead sponsor.

NCT NCT03248037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03248037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-masked, Placebo-controlled Evaluation of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation
Lead sponsor
Cornea Research Foundation of America
Phase
Phase 3
Overall status
Completed
Start date
September 5, 2017
Completion date
July 9, 2019
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bullous keratopathy, fuchs' endothelial dystrophy